{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:35:46Z","timestamp":1792017346365,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bmc.2026.118685","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:19:05Z","timestamp":1777735145000},"page":"118685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["New potential HIV-1 inhibitors, analogues to efavirenz, containing the isatin core"],"prefix":"10.1016","volume":"139","author":[{"given":"Gustavo P.","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora I.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana J.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacio V.A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Claudio F.","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubia","family":"Boechat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118685_bb0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barr\u00e9-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118685_bb0010","author":"UNAIDS"},{"key":"10.1016\/j.bmc.2026.118685_bb0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1351\/pac199870030567","article-title":"Recent developments in the chemotherapy of HIV infections","volume":"70","author":"De Clercq","year":"1998","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0020","first-page":"129","article-title":"Review of HIV-1 reverse transcriptase three-dimensional structure: implications for drug design","volume":"1","author":"Nanni","year":"1998","journal-title":"PD3"},{"key":"10.1016\/j.bmc.2026.118685_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pbiomolbio.2004.07.001","article-title":"Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"88","author":"Das","year":"2005","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.bmc.2026.118685_bb0030","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1021\/acs.jmedchem.6b00738","article-title":"Design, synthesis, and evaluation of thiophene[3,2-d]pyrimidine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors with significantly improved drug resistance profiles","volume":"59","author":"Kang","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/biom13010088","article-title":"Efavirenz: history, development and future","volume":"13","author":"Costa","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2026.118685_bb0040","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.bmc.2026.118685_bb0045","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2352-3018(20)30238-1","volume":"7","author":"Calmy","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.bmc.2026.118685_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejmech.2014.10.065","article-title":"A review on recent developments of indole-containing antiviral agents","volume":"89","author":"Zhang","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0055","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/S0960-894X(99)00486-2","article-title":"Synthesis and evaluation of analogs of Efavirenz (SUSTIVATM) as HIV-1 reverse transcriptase inhibitors","volume":"9","author":"Patel","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118685_bb0060","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/S0960-894X(99)00565-X","article-title":"Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA)","volume":"9","author":"Patel","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118685_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejmech.2015.11.025","article-title":"Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: approaches based on its medicinal chemistry","volume":"108","author":"Bastos","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/ml100164p","article-title":"Drawing the PDB - protein-ligand complexes in two dimensions","volume":"1","author":"Stierand","year":"2010","journal-title":"Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118685_bb0075","doi-asserted-by":"crossref","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","article-title":"PLIP 2025: introducing protein-protein interactions to the protein-ligand interaction profiler","volume":"53","author":"Schake","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2026.118685_bb0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/157340607782360326","article-title":"Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-ones","volume":"3","author":"Boechat","year":"2007","journal-title":"Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0085","series-title":"Funda\u00e7\u00e3o Oswaldo Cruz- Fiocruz, Rio de Janeiro, Brazil, PCT\/BR2016\/000050","author":"Boechat","year":"2017"},{"key":"10.1016\/j.bmc.2026.118685_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300560","article-title":"New azaaurone derivatives as potential multitarget agents in HIV-TB coinfection","volume":"357","author":"Leite","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"issue":"1","key":"10.1016\/j.bmc.2026.118685_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147225","article-title":"Ribonuclease H\/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of Isatin-based compound RMNC6","volume":"11","author":"Corona","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118685_bb0100","first-page":"146","article-title":"Dihydropyrimidinone-Isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"71","author":"Devale","year":"2017","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0105","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2174\/1568026618666181029150118","article-title":"New efavirenz derivatives and 1,2,3-triazolyl-phosphonates as inhibitors of reverse transcriptase of HIV-1","volume":"18","author":"Costa","year":"2018","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/pharmaceutics16070889","article-title":"Recent advances in the development of hybrid drugs","volume":"16","author":"Morais","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmc.2026.118685_bb0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/17460441.2024.2322990","article-title":"Molecular hybridization: a powerful tool for multitarget drug discovery","volume":"19","author":"Pinheiro","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2026.118685_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111699","article-title":"Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity","volume":"183","author":"Trivedi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112071","article-title":"Discovery, synthesis, and optimization of an N-alkoxy indolylacetamide against HIV-1 carrying NNRTI-resistant mutations from the Isatis indigotica root","volume":"189","author":"Xu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0130","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1021\/jo00014a050","article-title":"Convenient method for the titration of amide base solutions","volume":"56","author":"Ireland","year":"1991","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0135","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1080\/14756366.2020.1809388","article-title":"Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors","volume":"35","author":"Firoozpour","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.00749-06","article-title":"Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification","volume":"51","author":"Aguiar","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118685_bb0145","first-page":"432","article-title":"How much do antiretroviral drugs penetrate into the central nervous system?","volume":"4","author":"Ene","year":"2011","journal-title":"J Med Life"},{"key":"10.1016\/j.bmc.2026.118685_bb0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14787210.2.3.367","article-title":"Nevirapine in the treatment of HIV","volume":"2","author":"Milinkovic","year":"2004","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.bmc.2026.118685_bb0155","first-page":"271","article-title":"Establishment of an MT4 cell line persistently producing infective HIV-1 particles","volume":"39","author":"Gyuris","year":"1992","journal-title":"Acta Microbiol Hung"},{"key":"10.1016\/j.bmc.2026.118685_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jviromet.2016.03.008","article-title":"Comparison of three quantification methods for the TZM-bl pseudovirus assay for screening of anti-HIV-1 agents","volume":"233","author":"Xing","year":"2016","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bmc.2026.118685_bb0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1189\/jlb.0503219","article-title":"Macrophage HIV-1 infection and the gastrointestinal tract reservoir","volume":"74","author":"Smith","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bmc.2026.118685_bb0170","article-title":"The reservoir of latent HIV","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2026.118685_bb0175","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/jm040158k","article-title":"New approaches toward anti-HIV chemotherapy","volume":"48","author":"De Clercq","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0180","article-title":"Influence of combination antiretroviral therapy on HIV-1 serological responses and their implications: a systematic review and Meta-analysis","volume":"13","author":"Liang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2026.118685_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1159276","article-title":"Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV\/AIDS disease","volume":"4","author":"Tugizov","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.bmc.2026.118685_bb0190","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41598-019-41594-3","article-title":"Exponential consensus ranking improves the outcome in docking and receptor ensemble docking","volume":"9","author":"Palacio-Rodr\u00edguez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118685_bb0195","author":"Molinspiration"},{"key":"10.1016\/j.bmc.2026.118685_bb0200","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/17460441.2023.2228199","article-title":"Today\u2019s drug discovery and the shadow of the rule of 5","volume":"18","author":"Young","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2026.118685_bb0205","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.5935\/1984-6835.20150074","article-title":"O Efavirenz: Rela\u00e7\u00e3o Estrutura-Atividade e M\u00e9todos de S\u00edntese","volume":"7","author":"Costa","year":"2015","journal-title":"Rev Virtual Qu\u00edm"},{"key":"10.1016\/j.bmc.2026.118685_bb0210","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.bmc.2026.118685_bb0215","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/1568026033452096","article-title":"The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery","volume":"3","author":"Lin","year":"2003","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2026.118685_bb0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Waterbeemd","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.bmc.2026.118685_bb0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.bmc.2026.118685_bb0230","article-title":"Recent advances in the prediction of pharmacokinetics properties in drug design studies: a review","volume":"17","author":"Pantale\u00e3o","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118685_bb0235","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","article-title":"Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design","volume":"53","author":"Lansdon","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118685_bb0245","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2026.118685_bb0250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118685_bb0255","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J Phys Chem A"},{"key":"10.1016\/j.bmc.2026.118685_bb0260","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118685_bb0265","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118685_bb0270","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1021\/ct200162x","article-title":"Nucleic acids force field based on reference quantum chemical calculations of glycosidic torsion profiles","volume":"7","author":"Zgarbov\u00e1","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118685_bb0275","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2026.118685_bb0285","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0290","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2026.118685_bb0295","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","article-title":"A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations","volume":"22","author":"Kr\u00e4utler","year":"2001","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0300","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2026.118685_bb0305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cplett.2003.12.039","article-title":"Molecular dynamics simulations of water and biomolecules with a Monte Carlo constant pressure algorithm","volume":"384","author":"Aqvist","year":"2004","journal-title":"Chem Phys Lett"},{"key":"10.1016\/j.bmc.2026.118685_bb0310","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/ct800573m","article-title":"Bad seeds sprout perilous dynamics: stochastic thermostat induced trajectory synchronization in biomolecules","volume":"5","author":"Sindhikara","year":"2009","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118685_bb0315","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0320","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118685_bb0325","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00894-007-0233-4","article-title":"Optimization of parameters for semi-empirical methods V: modification of NDDO approximations and application to 70 elements","volume":"13","author":"Stewart","year":"2007","journal-title":"J Mol Model"},{"key":"10.1016\/j.bmc.2026.118685_bb0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/minf.201400132","article-title":"Improving AutoDock Vina using random Forest: the growing accuracy of binding affinity prediction by the effective exploitation of larger data sets","volume":"34","author":"Li","year":"2015","journal-title":"Mol Inform"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:10:23Z","timestamp":1783109423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S0968089626001410"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118685","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New potential HIV-1 inhibitors, analogues to efavirenz, containing the isatin core","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118685"}}